Cardiovascular disease supplements refer to nutritional products designed to complement traditional approaches in managing cardiovascular health. These supplements typically contain a variety of vitamins, minerals, antioxidants, and other bioactive compounds that are believed to support heart health. Common cardiovascular disease supplements include omega-3 fatty acids, coenzyme Q10 (CoQ10), magnesium, vitamin D, and various antioxidants such as vitamin C and E. Omega-3 fatty acids, found in fish oil supplements, are often associated with reducing triglycerides and inflammation, while CoQ10 plays a role in cellular energy production. These supplements are commonly taken by individuals aiming to enhance their cardiovascular health, either as part of preventive measures or in conjunction with prescribed medications. It's crucial for individuals considering cardiovascular disease supplements to consult with healthcare professionals, as the effectiveness and safety of these supplements may vary, and potential interactions with medications should be carefully evaluated.
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Not So Idiopathic After All: Genotype, Phenotype and IL-1 Blockade Response Converge in Recurrent Pericarditis
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Beyond the Heart in Cardiovascular Magnetic Resonance Imaging: Prevalence and Clinical Significance of Incidental Extracardiac Findings
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Cardiovascular mortality in colon cancer a patient characteristics analysis: Population-based study
Nouf, KAU, Saudi Arabia
Title : Improving Screening and Treatment of Iron Deficiency in Patients with Heart Failure with Reduced Ejection Fraction: A Two-Cycle Quality Improvement Project
Danish Malik, University Hospitals Dorset NHS Foundation Trust, United Kingdom